Genomic medicine accessible in India if technology is sourced locally

Speaking at the press conference, panellists explained the possibilities genomic medicine can create in terms of creating rare diseases, genetic disorders.

Published: 19th November 2022 12:59 PM  |   Last Updated: 19th November 2022 12:59 PM   |  A+A-

Bengaluru Tech Summit 2022

(Photo |bengalurutechsummit.com(

By Express News Service

BENGALURU: Genomic medicine is called to be the future of medicine but it can only be more accessible and inexpensive if efforts are made to make the technology more localised, experts said. 

Speaking at the press conference - The Future of Genomic Medicine at the Bengaluru Tech Summit 2022, panellists explained the possibilities genomic medicine can create in terms of creating rare diseases, genetic disorders and playing a huge role in changing the healthcare system. 

Professor Siddharth Jhunjhunwala, associate professor, Indian Institute of Science, said, in the current scenario, there is structural support provided to the startups in terms of technology. However, more support is needed from the government’s end in terms of education and research and development.

The technology advancement will only be beneficial if it will be more localised. Currently, most of the resources are imported making it unaffordable to most people. Jhunjhunwala opined that if research is done on more common diseases (affecting more people, like diabetes) it can help make it more accessible and economical as well.  

Dr Vijay Chandru, panellist and commissioner at Lancet Citizen's Commission on reimagining India's health System, explained how gene therapy could help treat rare diseases like Duchenne Muscular Therapy (DMD), thalassemia, and cancer as well. Only, limitations were the high costs involved in production and manufacturing, gene therapy being labour intensive and current approved therapies not accessible to all. 

Treatment of rare diseases using gene therapy can only be afforded by very few people in the society due to its expensive costs, professor Jhunjhunwala said. There are endless possibilities for genomic medicine with gene therapy, in risk assessment of diseases and understanding impacts and outcomes as well or various diseases. 

Dr. Vishal Rao, U S, director, head neck surgical oncology and robotic surgery and dean, centre of academics & research, HCG Cancer Centre said the country did not lack in any prospects, for technology, infrastructure, talent and resources. Only cumulative efforts need to be taken to ensure entire technology is being ‘created’ in India.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp